terazosin

Generic: terazosin hydrochloride

Labeler: nucare pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin hydrochloride
Labeler nucare pharmaceuticals, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 2 mg/1

Manufacturer
NuCare Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 66267-389
Product ID 66267-389_1fa6d444-4cb4-0343-e063-6394a90aa95a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075317
Listing Expiration 2026-12-31
Marketing Start 2004-12-20

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 66267389
Hyphenated Format 66267-389

Supplemental Identifiers

RxCUI
313217
UPC
0366267389303
UNII
D32S14F082

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin hydrochloride (source: ndc)
Application Number ANDA075317 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 90 CAPSULE in 1 BOTTLE (66267-389-90)
source: ndc

Packages (1)

66267-389-90 90 CAPSULE in 1 BOTTLE (66267-389-90)

Ingredients (1)

terazosin hydrochloride (2 mg/1)

Linked Drug Pages (1)

Terazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1fa6d444-4cb4-0343-e063-6394a90aa95a", "openfda": {"upc": ["0366267389303"], "unii": ["D32S14F082"], "rxcui": ["313217"], "spl_set_id": ["40e5ae44-708a-15a3-e054-00144ff8d46c"], "manufacturer_name": ["NuCare Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE (66267-389-90)", "package_ndc": "66267-389-90", "marketing_start_date": "20161109"}], "brand_name": "Terazosin", "product_id": "66267-389_1fa6d444-4cb4-0343-e063-6394a90aa95a", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "66267-389", "generic_name": "Terazosin Hydrochloride", "labeler_name": "NuCare Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA075317", "marketing_category": "ANDA", "marketing_start_date": "20041220", "listing_expiration_date": "20261231"}